U.S. Markets close in 2 hrs 49 mins

Gilead Sciences Raises Dividend by Double Digits

- By Timothy J. McIntosh

Gilead Sciences' (GILD) dividend was increased by a solid 11%. Its overall yield is now 3.08%. The company started paying a dividend in 2015.

Gilead is a large U.S. based biotechnology company . The health care company discovers and develop drugs products treat infectious diseases. Its product portfolio is concentrated in the HIV and hepatitis B and C arenas. With several acquisitions, the company also now has moved into cardiovascular, cancer and pulmonary. Gilead's primary products include Truvada, Viread, Genvoya, Stribild, Harvonia and Sovaldi. The company is located in Foster City, California, and was founded in 1987.